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Abstract
Exercise is a double-edged sword: when practiced in moderation, it increases the expression of antioxidant en-
zymes, but when practiced strenuously it causes oxidative stress and cell damage. In this context, polymorphisms in
the interleukin (IL)-6 gene should be investigated better because they can influence performance, at least in exercise
that generates oxidative stress and leads to muscular injuries with consequent inflammation. In this work, we investi-
gated the influence of IL-6 –174 G/C polymorphism on tissue damage and inflammation markers, lipid peroxidation,
hemogram and lipid profile of runners before and after ingestion of 400 mg of pequi oil in capsules supplied daily for
14 consecutive days. The IL-6 genotypes were associated with significant differences in lipid peroxidation, with the
CC mutant having lower values. There were also significant differences among these genotypes in the response to
supplementation with pequi oil, exercise-induced damage and C-reactive protein (CRP) levels. The best protection
against damage was observed with the heterozygous genotype. Although the CC genotype showed an increase in
CRP levels after supplementation, the lack of a positive correlation between triglycerides and high-sensitivity CRP in
this mutant genotype after supplementation indicated a protective effect of pequi. These findings deserve further in-
vestigation, particularly with regard to the quantification of circulating IL-6 concentrations.
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Introduction
Regular physical activity, apart from enhancing the
expression of antioxidant enzymes, also induces a systemic
increase in many cytokines with anti-inflammatory proper-
ties that protect against chronic disorders associated with
low-grade systemic inflammation (Gomez-Cabrera et al.,
2008; Colombini et al., 2011; Miranda-Vilela, 2012). Simi-
larly, micro-injuries to skeletal muscle, resulting from reg-
ular exercise, lead to the recruitment of cytokines such as
interleukin-1 beta (IL-1) and tumor necrosis factor-alpha
(TNF-) that initiate and regulate the repair process. The
long-term anti-inflammatory effect of exercise is also me-
diated by muscle-derived interleukin 6 (IL-6) (Colombini
et al., 2011), which is involved in immune function, muscle
repair and hypertrophy following exercise-induced damage
(Eynon et al., 2011a). IL-6 stimulates circulating anti-
inflammatory IL-1Ra and IL-10 and inhibits the production
of pro-inflammatory TNF- (Colombini et al., 2011).
In contrast to regular exercise, strenuous exercise or
training above habitual intensity can lead to oxidative stress
through the enhanced formation of reactive oxygen and ni-
trogen species (RONS), causing muscle injuries and in-
flammation that can compromise performance and poten-
tially increase the future risk of cardiovascular disease
(CVD) in athletes (Miranda-Vilela, 2012; Miranda-Vilela
et al., 2011a, 2012). Strenuous exercise not only induces
lipid peroxidation, but also promotes inflammation,
changes in the immune cell count and the release of acute
phase proteins such as C-reactive protein (CRP) (Oleto et
al., 2011; Miranda-Vilela et al., 2009a, 2012; Miranda-
Vilela, 2012). The synthesis of CRP is, in turn, regulated by
cytokines, mostly IL-6 (Moleres et al., 2009); chronically
elevated levels of IL-6 are associated with vascular smooth
muscle growth, increased production of acute phase protein
and effects on lipid and lipoprotein metabolism, all of
which can contribute to an increased risk of CVD (Shen et
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al., 2008; Gan et al., 2013). Furthermore, an increase in the
circulating levels of cytosolic proteins such as aspartate
aminotransferase (AST), alanine aminotransferase (ALT)
and creatine kinase (CK) after exercise reflects cellular in-
jury and can be used as markers for exercise-induced dam-
age (Akimoto et al., 2010; Miranda-Vilela 2012; Miranda-
Vilela et al., 2012).
Physical exercise is thus a double-edged sword: when
regularly practiced in moderation, it increases the expres-
sion of antioxidant enzymes and should be considered an
antioxidant, but when practiced strenuously it causes oxi-
dative stress and cell damage (Gomez-Cabrera et al., 2008),
possibly leading to overtraining syndrome (Miranda-Vilela
et al., 2011a; Miranda-Vilela, 2012). These observations
have led to research into whether antioxidant supplemen-
tation could prevent the damaging effects of enhanced pro-
duction of RONS in response to exercise, thereby
improving athletic performance (Miranda-Vilela et al.,
2011a; Miranda-Vilela, 2012). In this context, pequi oil, a
carotenoid-rich oil extracted from the pulp of pequi
(Caryocar brasiliense Camb.), a typical fruit found in the
Brazilian Cerrado, has been shown to have anti-inflam-
matory properties, besides reducing arterial pressure, exer-
cise-induced anisocytosis and DNA and tissue damage
(Miranda-Vilela et al., 2009a,b, 2010, 2011a,b).
In addition to its natural antioxidants, pequi oil is
composed mainly of oleic (51.37-55.87%) and palmitic
(35.17-46.79%) fatty acids that modulate the triglyceride
(TG):cholesterol ratio in postprandial triglyceride-rich li-
poprotein (TRL) (Miranda-Vilela et al., 2009a,c). Post-
prandial and intestinally produced TRLs play an important
role in increasing the risk of atherogenesis (Bermúdez et
al., 2008; Varela et al., 2013), while the dietary substitution
of saturated fatty acids (SFA; mainly palmitic acid, 16:0)
with monounsaturated fatty acids (MUFA; mainly oleic
acid, 18:1 -9) influences protection against atherosclero-
sis by preventing excessive lipid accumulation in mono-
cyte/macrophage cells (Varela et al., 2013). In our previous
study, supplementation with pequi oil also reduced post-
prandial total cholesterol and low-density lipoprotein
(LDL) in runners (particularly men) > 45 years old; LDL is
considered an independent risk factor for CVD (Miranda-
Vilela et al., 2009a). Since elevated plasma CRP and LDL
have been associated with increased risk of CVD (Moleres
et al., 2009), pequi oil has been suggested as a means of de-
creasing the risk of atherogenesis in these groups of more
susceptible athletes (Miranda-Vilela et al., 2009a).
Despite these protective effects of pequi oil, some of
the responses in runners are influenced by genetic poly-
morphisms related to oxidative stress and inflammatory
markers (Miranda-Vilela et al., 2009b, 2010, 2011a,b; Ri-
beiro et al., 2013). Because some polymorphic genes are
able to modify the risk of various diseases, and physical fit-
ness has a genetic component, it would be interesting to
study variations in genes that can influence athletic perfor-
mance and pathogenic processes such as inflammatory
responses (Colombini et al., 2011). In this regard, poly-
morphisms in the IL-6 gene need to be investigated better
because they can influence performance, at least in those
cases where the oxidative stress generated by strenuous ex-
ercise leads to muscle injuries and consequent inflamma-
tion.
The human IL-6 gene is located on the short arm of
chromosome 7 (7p21) (Capurso et al., 2004) and has about
50 single-nucleotide polymorphisms (SNPs) in its pro-
moter region (Pereira et al., 2011). Among these SNPs, a
functional –174 G/C SNP (rs1800795) has been reported to
affect the plasma levels of this cytokine, with the mutant C
allele expressing lower levels of plasma IL-6 than the
wild-type G allele (Fishman et al., 1998; Capurso et al.,
2004). IL-6 regulates the immune response by acting on B
and T cells, but also acts on hematopoietic stem cells,
megakaryocytes and hepatocytes (e.g., mesangial cells),
nerve cells, keratinocytes and plasmacytoma/myeloma
cells (Hirano et al., 1990) such that changes in the expres-
sion of this cytokine can influence these cells. Indeed, a de-
ficiency in IL-6 alters the balance between the proliferation
and differentiation of progenitor cells of the granulocytic-
monocytic, megakaryocytic and erythroid lineages into
mature blood cells, leading to abnormal levels of commit-
ted progenitors in these lineages and to a slow recovery
from hematopoietic ablation (Bernad et al., 1994).
Because the IL-6 –174 G/C polymorphism (SNP
rs1800795) has been associated with exercise-related phe-
notypes (Eynon et al., 2011a,b), and since diet can affect an
individual’s genes and these can in turn affect the response
to supplementation (Miranda-Vilela et al., 2011a; Miran-
da-Vilela, 2012; Ribeiro et al., 2013), in this work we in-
vestigated the influence of this IL-6 polymorphism on the
levels of creatine kinase (CK), aspartate aminotransferase
(AST), alanine aminotransferase (ALT), acute phase pro-
teins (C-reactive protein - CRP and high-sensitivity CRP –
hs-CRP), lipid peroxidation (evaluated by the TBARS as-
say), complete hemogram, and lipid profile of runners be-
fore and after ingestion of 400 mg of pequi oil in capsules
supplied daily for 14 consecutive days. Overall, we sought
to evaluate how individual genetic differences in IL-6 –174
G/C affected each athletes response to antioxidant supple-
mentation with pequi oil during oxidative stress while exer-
cising, and how the diet with pequi oil interacted with an
individual’s IL-6 gene to influence the response to this
supplementation.
Materials and Methods
Study design and participants
Initially, 139 trained street runners of both genders
(53 females and 86 males) and different age groups were re-
cruited based on previously reported criteria (Miranda-
Vilela et al., 2009a,b, 2010, 2011a,b; Ribeiro et al., 2013).
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Briefly, the tests were done after two races in the same en-
vironment and under closely comparable conditions, ac-
cording to the type, intensity and length of the athletes
weekly training, before and after the ingestion of 400 mg of
pequi oil in capsules supplied daily for 14 consecutive days.
There were no significant changes in the daily routine,
training or lifestyle of the runners between the first and sec-
ond race, except for the ingestion of pequi oil capsules. The
athletes could choose the distance that they would cover
(4-21 km) based on the type, intensity and length of their
weekly training so as to guarantee no additional physical
stress beyond that which they were accustomed to. This ap-
proach avoided differences in the amount or intensity of
training and consequent increase in oxidative stress. Only
those athletes who followed the instructions correctly and
participated in both races were enrolled in the study, which
involved 125 athletes (49 females and 76 males), aged
15-67 years old.
This study was done according to the guidelines laid
down in the Declaration of Helsinki, and the procedures
were approved by the Ethics Committee of the University
of Brasília and by the National Commission for Ethics in
Research (CONEP). Written informed consent was ob-
tained from all subjects.
Preparation of capsules
Pequi oil, the composition of which has previously
been described (Miranda-Vilela et al., 2009a,b,c, 2010;
Miranda-Vilela et al., 2011a,b; Ribeiro et al., 2013; Miran-
da-Vilela et al., 2014), was extracted by cold maceration
using chloroform as a solvent (Miranda-Vilela et al.,
2009c) and incorporated in Aerosil (colloidal silicon diox-
ide) q.s.p. (Miranda-Vilela et al., 2009a,b, 2010, 2011a,b).
The capsule production was patented as number
PI0601631-6 (National Institute of Industrial Property –
INPI) and a voucher of the pequi specimen (C. brasiliense
Camb.) was deposited in the herbarium of the University of
Brasilia (UnB) by Professor Cassia Munhoz (PhD) (collec-
tion number 7402, registration number 165.857).
Procedures and measurements
Waist circumference (WC), hip circumference,
waist-hip ratio and body mass index (BMI) were checked
before the first race as previously reported (Miranda-Vilela
et al., 2009a). Peripheral blood samples collected immedi-
ately after the two races in Vacutainer tubes containing
EDTA were used to perform immune cell counting and
genotyping, while serum samples were used to quantify
CK, AST, ALT, acute phase proteins (CRP and hs-CRP),
postprandial lipid profile and TBARS.
Hemogram and biochemical analyses
A complete blood count or hemogram was done in an
automated analyzer (Cell-Dyn 3700, Abbott Diagnostics,
Chicago, Illinois, US); serum ALT, AST, CK, CRP and
postprandial lipid profile analyses were run on an
automated chemistry analyzer ADVIA 1650 (Bayer Diag-
nostics, Greenburgh, NY, US) and serum hs-CRP was mea-
sured by an immunometric assay (Immulite 2000, DPC,
Medlab) using the appropriate chemical reagents, controls
and protocols of the manufacturers. The TBARS assay was
done according to Wasowicz et al. (1993) and the fluores-
cence was measured with a Jasco FP-777 spectrofluoro-
meter (excitation: 525 nm, emission: 547 nm).
Genotyping of the polymorphism
Genomic DNA was isolated from the buffy-coat layer
using a Blood genomic Prep mini spin kit (GE Healthcare,
Buckinghamshire, England). DNA samples were quanti-
fied in a Nanovue spectrophotometer (GE Healthcare), di-
luted in milli-Q water to a final concentration of 50 ng/L
and stored at -20°C until analysis. DNA samples were am-
plified in an MJ PTC-100 thermocycler (MJ Research Inc.,
Waltham, MA, USA). The IL-6 genotypes were deter-
mined by allele-specific amplification (Eynon et al.,
2011b). The PCR products were separated by electrophore-
sis in 6% non-denaturing polyacrylamide gels and visual-
ized by staining with silver nitrate.
Statistical analyses
The minimum sample size was estimated by power
analysis based on the statistical analysis of quantitative data
and a maximum tolerable sampling error (standard error or
sampling error) of 0.05-0.20, depending on the population
variability for the reference intervals of the laboratory tests
and samples after stratification of the entire group (Ribeiro
et al., 2013; Barbosa et al., 2014).
The genotype distributions were tested for Hardy-
Weinberg equilibrium (HWE) by the Chi-square (2) test,
using the Genepopweb statistical program, version 4.2
(http://genepop.curtin.edu.au). Values of p > 0.05 were in-
dicative of HWE. The same program was used to calculate
the allelic and genotypic frequencies of each locus, as well
as genetic diversity parameters such as observed hetero-
zygosity (Ho), expected heterozygosity (He) and inbreed-
ing coefficient (FIS).
Statistical analysis was done using SPSS (Statistical
Package for the Social Sciences) version 17.0. The data
were expressed as the mean  SD (standard deviation) and
values of p < 0.05 were considered statistically significant.
The continuous variables were tested for normal distribu-
tion with the Shapiro-Wilk test. For the parameters ana-
lyzed, possible differences between the sexes were evalu-
ated by Students t-test or the Mann-Whitney U test
(non-normalized data), while differences among age
groups, distance covered and genotypes were evaluated by
ANOVA or the Kruskal-Wallis test (data not normally dis-
tributed), followed, respectively, by the Tukey or Mann-
Whitney U tests. Students paired t-test or the Wilcoxon
matched pairs test (when the data were not normally dis-
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tributed) was used to assess differences in before-after
comparisons of supplementation with pequi oil.
The possible correlations between the parameters ge-
netic polymorphisms/sex, genetic polymorphisms/age
group and genetic polymorphisms/distance covered were
analyzed using the Chi-square correlation test. As the cor-
relations sex/age group, sex/distance covered, age
group/distance covered have already been published (Mi-
randa-Vilela et al., 2009a; Ribeiro et al., 2013), they will
not be presented here. The Spearman correlation test was
used to assess correlations between qualitative variables
(genotypes) and laboratory tests, while correlations be-
tween quantitative variables were tested by the Pearson
(normalized data) or Spearman (data not normally distrib-
uted) correlation tests (Barbosa et al., 2014).
The odds ratio (OR) with 95% confidence intervals
(CI) was also calculated to estimate the relative chance of
risk or protection for higher levels of CK, AST, ALT, CRP,
hs-CRP and lipid peroxidation. To calculate the OR for the
biochemical tests, the parameters > or < than the maximum
reference limit were considered, and were: CK: 145 U/L
(female) and 170 U/L (male) (Freire et al., 2008; Schumann
and Klauke, 2003), AST: 31 U/L (female) and 37 U/L
(male), ALT: 35 U/L (female) and 40 U/L (male) (Freire et
al., 2008), and CRP and hs-CRP: 1.0 mg/L for both sexes,
based on the low risk of having a heart attack as defined by
the American Heart Association and the US Center for Dis-
eases Control (Ridker, 2003), with women usually having
lower values than men (Rifai and Ridker, 2003). For the
TBARS assay the median was used, i.e., > 0.027 and
< 0.027 nmol of MDA/mL for both sexes (Akimoto et al.,
2010).
Results
The frequencies of the IL-6 –174 G/C (SNP
rs1800795) genotypes were in Hardy-Weinberg equilib-
rium (p > 0.05) and the distribution of their allele and geno-
type frequencies, as well as the genetic diversity parameters
and HWE data for the Chi-square (2) test are shown in Ta-
ble 1. There were no significant differences in the distribu-
tion of IL-6 genotypes between the sexes (Table 2), among
age groups (Table 3) or in relation to the distance covered
(Table 4).
For the biochemical tests, there were significant dif-
ferences in the TBARS values of the genotypes CC and GG
(p=0.011) and CC and GC (p=0.028) before supplemen-
tation with pequi oil. After supplementation, these differ-
ences persisted between CC and GG (p=0.023) and
appeared for GC and GG (p=0.041). In both cases, before
and after pequi, the wild type (GG) genotype showed high-
er lipid peroxidation [higher MDA (malondialdehyde) val-
ues in the TBARS assay]. Significant differences in the
before-after comparison were observed for the GC geno-
type in relation to the CK (p = 0.030) and AST (p = 0.030)
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values that were reduced after supplementation, and for the
CC genotype in which CRP was significantly increased
(p = 0.021) after supplementation with pequi, although still
within the limits of the reference value (Ridker, 2003) (Ta-
ble 5).
For the hemogram, supplementation with pequi re-
sulted in a significant difference only for the platelet devia-
tion weight (PDW) between the genotypes GC and GG
(p = 0.045), with the heterozygous genotype having the
higher values. However, in the before-after comparison,
several responses to supplementation were observed
among the IL-6 genotypes (Table 6).
The postprandial lipid profile revealed significant dif-
ferences after supplementation with pequi only between the
LDL values of the CC and GG genotypes (p=0.012) and CC
and GC (p=0.003), with the homozygous mutant genotype
(CC) having lower values. No significant differences were
observed in the before-after comparisons (Table 7).
Several correlations among the serum levels of the
biochemical parameters and postprandial lipid profile were
observed in the group as a whole and in the IL-6 genotypes.
In particular, there was a positive correlation between tri-
glycerides before vs hs-CRP, which was particularly re-
lated to the CC genotype (Table 8).
The OR with 95% CI indicated that individuals carry-
ing the wild type genotype (GG) were 2.9 times more likely
to have MDA values (TBARS assay) > 0.027 nmol/mL,
while the GC genotype decreased this risk. For females car-
rying the GG genotype, this risk was > 5.0, while for males,
there was a decreased risk for the CC, but not for GC, geno-
type (Table 9).
Discussion
The IL-6 –174 G/C polymorphism (SNP rs1800795)
tends to be quite variable in Caucasians, but in Asians and
Africans the frequency of the C allele is much lower than in
Caucasians, tending to be almost monomorphic for the
wild-type G allele (Gan et al., 2013). The Brazilian popula-
tion is very mixed, primarily because of five centuries of
interethnic crosses among Europeans (European coloniz-
ers, mainly represented by the Portuguese), Africans
(slaves) and Amerindians (the indigenous population)
(Parra et al., 2003; Hiragi et al., 2011; Lordelo et al., 2012;
Barbosa et al., 2014); this miscegenation can strongly in-
fluence the distribution of certain polymorphisms (Lordelo
et al., 2012; Barbosa et al., 2014). Moreover, Brazil’s large
geographic size and the fact that different population
groups have moved to different parts of the country has re-
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Table 3 - Distribution of IL-6 –174 G/C (SNP rs1800795) genotypes in relation to age group (years old). The results are expressed as a percentage (%) in
relation to the total sample size of each group.
IL-6 genotypes 15-19 (%)
[N=20]
20-24 (%)
[N=25]
25-29 (%)
[N=25]
30-34 (%)
[N=12]
35-39 (%)
[N=16]
40-44 (%)
[N=10]
> 45 (%)
[N=17]
p
GG 10 (50) 10 (40) 14 (56) 4 (33.3) 9 (56.3) 4 (40) 8 (47.1)
GC 5 (25) 10 (40) 10 (40) 7 (58.3) 6 (37.5) 6 (60) 8 (47.1) 0.717
CC 5 (25) 5 (20) 1 (4) 1 (8.3) 1 (6.3) 0 (0) 1 (5.9)
The p value was calculated with the Kruskal-Wallis test using SPSS (Statistical Package for the Social Sciences), version 17.0.
Table 4 - Distribution of IL-6 –174 G/C (SNP rs1800795) genotypes relative to the distance covered (km). The results are expressed as a percentage (%)
in relation to the total sample size of each group.
IL-6 genotypes 4-5 (%) [N=50] 6-7 (%) [N=38] 8-10 (%) [N=30] 16-21 (%) [N=7] p
GG 23 (46) 21 (55.3) 11 (36.7) 4 (57.1)
GC 19 (38) 13 (34.2) 18 (60) 2 (28.6) 0.697
CC 8 (16) 4 (10.5) 1 (3.3) 1 (14.3)
The p value was calculated with the Kruskal-Wallis test using SPSS (Statistical Package for the Social Sciences), version 17.0.
Table 2 - Distribution of IL-6 –174 G/C (SNP rs1800795) genotypes in relation to the total number of subjects and gender. The results are expressed as a
percentage (%) in relation to the total sample size of each group.
IL-6 genotypes Total (%) [N=125] Male (%) [N=76] Female (%) [N=49] p
GG 59 (47.2) 38 (50) 21 (42.9)
GC 52 (41.6) 29 (38.2) 23 (46.9) 0.569
CC 14 (11.2) 9 (11.8) 5 (10.2)
The p value was calculated with the Mann-Whitney U test using SPSS (Statistical Package for the Social Sciences), version 17.0.
sulted in considerable phylogeographical heterogeneity
(Parra et al., 2003). As the population of Brasilia (the Fed-
eral Capital) is formed by migrants from all regions of
Brazil, it tends to reflect the Brazilian population better
than any other region (Miranda-Vilela et al., 2009d; Hiragi
et al., 2011). In this regard, our results confirm a major in-
fluence of European ancestry in the IL-6 polymorphism
studied here. Moreover, as there were no sex-, age- or dis-
tance-related differences in the distribution of the IL-6 ge-
notypes, we have no reason to reject the hypothesis that the
significant differences seen here reflected each individuals
IL-6 response to antioxidant supplementation with pequi,
and possibly also a direct interaction of pequi with the IL-6
gene to influence the response to this supplementation.
Although we did not examine the biomarkers before
each race, most of the exercise-induced physiological and
biochemical changes have already been well documented
(Ji and Leichtweis, 1997; Kargotich et al., 1998; Kasapis
and Thompson, 2005; Mattusch et al., 2000; Urso and
Clarkson, 2003; Brancaccio et al., 2007; Cruzat et al.,
2007; Ferreira et al., 2007; Mougios, 2007) and our study
did not aim to evaluate such alterations. We undertook a
controlled before-after study in which observations are
made before and after the implementation of an interven-
tion; in our case, before (first race) and after (second race)
intervention with pequi oil. This type of study is validated
in the scientific literature (Meads and Davenport, 2009)
and, although it has some limitations compared to random-
ized placebo-controlled studies, we followed all of the rec-
ommended steps to guarantee quality control and the
validity of our study (American College of Physicians,
1999; Meads and Davenport, 2009), as previously reported
(Miranda-Vilela et al., 2009a,b, 2010, 2011a,b; Ribeiro et
al., 2013). Our results support the proposed hypothesis
since the values observed did not exceed the reference lim-
its determined for clinical purposes (Ridker, 2003;
Schumann and Klauke, 2003; Freire et al., 2008), and much
less for athletes (Mougios, 2007).
In addition to increasing oxygen consumption and in-
ducing oxidative stress, exercise can initiate an inflamma-
tory process that is regulated by cytokines, mostly IL-6
(Moleres et al., 2009). Since the IL-6 –174 G/C polymor-
phism is associated with serum IL-6 and/or CRP levels
(Szydlowski et al., 2013), our results demonstrated that
pequi oil may remove the positive association between tri-
glycerides and hs-CRP seen in the homozygous mutant
IL-6 CC genotype before (but not after) pequi. Further-
more, pequi oil may promote a non-significant increase in
triglycerides (Miranda-Vilela et al., 2009a) because of its
natural triglyceride (TG) composition (Segall et al., 2006;
Miranda-Vilela et al., 2009c). Since individuals genetically
predisposed to higher IL-6 secretion may be at risk of
dyslipidemia, especially during the postprandial phase, it
has been suggested that the IL-6 –174 G/C polymorphism
determines the difference in both fasting and postprandial
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Table 7 - Influence of IL-6 –174 G/C polymorphism (SNP rs1800795) on the postprandial lipid profile before and after supplementation with pequi oil.
IL-6 geno-
types
Total cholesterol
(mg/dL)
Triglycerides (mg/dL) HDL (mg/dL) LDL (mg/dL) VLDL (mg/dL)
Before After Before After Before After Before After Before After
GG 187.37 ±
37.43
186.04 ±
35.98
116.06 ±
66.43
116.72 ±
55.42
54.02 ±
13.90
53.07 ±
13.80
109.68 ±
28.56
108.85 ±
27.77
23.21 ±
13.29
23.34 ±
11.08
GC 193.22 ±
39.60
193.29 ±
33.71
111.35 ±
55.53
116.41 ±
46.27
55.14 ±
12.87
55.98 ±
13.32
116.19 ±
35.36
113.91 ±
29.26
22.27 ±
11.11
23.28 ±
9.25
CC 169.57 ±
35.67
170.21 ±
32.63
108.21 ±
58.52
130.86 ±
63.45
51.93 ±
12.99
54.50 ±
16.22
96.00 ±
26.19
89.54 ±
21.75a,b
21.64 ±
11.70
26.17 ±
12.69
p 0.126 0.086 0.945 0.747 0.368 0.313 0.149 0.012 0.945 0.747
The data are expressed as the mean  SD. HDL – high-density lipoprotein, LDL – low-density lipoprotein, VLDL – very-low-density lipoprotein,
mg/dL= milligram per deciliter. P values for total cholesterol were calculated by ANOVA, while those for the other parameters were calculated by the
Kruskal-Wallis test. The lowercase letters indicate significant differences detected between genotypes in the 2 X 2 comparisons, where a and b indicate
significance compared to the GG and GC genotypes, respectively.
Table 8 - Correlation between total cholesterol and other serum lipids in the whole group and in relation to the IL-6 –174 G/C genotypes.
Group Comparison Correlation p
coefficient
Whole group Total cholesterol before vs
Triglycerides before 0.366 0.000
HDL before 0.409 0.000
LDL before 0.905 0.000
VLDL before 0.366 0.000
Total cholesterol after vs
Triglycerides after 0.365 0.000
HDL after 0.406 0.000
LDL after 0.897 0.000
VLDL after 0.365 0.000
Triglycerides before vs
VLDL before 1.000 0.000
hs-CRP before 0.197 0.041
Triglycerides after vs
HDL after -0.182 0.049
VLDL after 1.000 0.000
IL-6 GG genotype Total cholesterol before vs
Triglycerides before 0.444 0.003
LDL before 0.554 0.000
VLDL before 0.463 0.002
Total cholesterol after vs
Triglycerides after 0.432 0.004
HDL after -0.304 0.045
LDL after 0.451 0.002
VLDL after 0.431 0.004
Triglycerides before vs
HDL before -0.363 0.017
VLDL before 1.000 0.000
Triglycerides after vs
TG metabolism and that this phenomenon could be respon-
sible for the observed association of this genetic variant
with a risk for CVD (Shen et al., 2008). C-reactive protein
(CRP) is an acute phase reactant and indicator of inflamma-
tion that promotes lipid accumulation in the atherosclerotic
plaque and exerts direct effects on endothelial cells, thereby
contributing to endothelial dysfunction (Erbel et al., 2008).
CRP and hs-CRP measure the same molecule in blood, but
hs-CRP has been developed to detect CRP at lower levels
and is therefore much more sensitive for diagnostic pur-
poses (Rifai and Ridker, 2003). The levels of hs-CRP can
be used to predict future cardiovascular disease in seem-
ingly healthy middle-aged adults (Erbel et al., 2008), and
the lack of correlation after pequi supplementation in the
present study suggested a protective effect of pequi oil, pri-
marily for the IL-6 CC genotype.
Pequi oil has a high concentration of mono-
unsaturated oleic (MUFA) and saturated palmitic (SFA)
fatty acids that are anti- and pro-atherogenic agents, respec-
tively (Aguilar et al., 2012). This oil is also rich in natural
antioxidants such as carotenoids (Azevedo-Meleiro and
Rodriguez-Amaya, 2004; Oliveira et al., 2006; Lima et al.,
2007) and vitamin E (-tocopherol), both of which are en-
countered in cooked pulp (Cardoso et al., 2013). Thus, al-
though pequi oil has been associated with atherogenic
worsening of the lipid profile (Aguilar et al., 2012), it has
562 IL-6 SNP influences antioxidant supplementation
Group Comparison Correlation p
coefficient
HDL after -0.426 0.004
VLDL after 1.000 0.000
HDL before vs
VLDL before -0.363 0.017
HDL after vs
VLDL after -0.426 0.004
IL-6 GC genotype Total cholesterol before vs
Triglycerides before 0.318 0.031
LDL before 0.544 0.000
VLDL before 0.318 0.031
Total cholesterol after vs
LDL after 0.548 0.000
Triglycerides before vs
VLDL before 1.000 0.000
Triglycerides after vs
VLDL after 1.000 0.000
IL-6 CC genotype Triglycerides before vs
VLDL before 1.000 0.000
hs-CRP before 0.843 0.001
Total cholesterol after vs
LDL after 0.756 0.018
Triglycerides after vs
VLDL after 1.000 0.000
Table 8 - Cont.
Table 9 - Odds ratios (OR) and 95% confidence intervals (CI).
Comparisons OR (95% CI) p
Total group IL-6 GG and TBARS after > 0.027 nmol of MDA/mL 2.917 (1.407-6.047) 0.004
IL-6 GC and TBARS after > 0.027 nmol of MDA/mL 0.462 (0.222-0.961) 0.046
Gender Male IL-6 CC and TBARS before > 0.027 nmol of MDA/mL 0.129 (0.015-1.087) 0.031
Female IL-6 GG and TBARS after > 0.027 nmol of MDA/mL 5.278 (1.535-18.148) 0.007
IL-6 GC and TBARS after > 0.027 nmol of MDA/mL 0.232 (0.070-0.770) 0.015
also been reported to efficiently reduce exercise-induced
inflammation (Miranda-Vilela et al., 2009a). This anti-
inflammatory action may be associated not only with the
antioxidant properties of the oil, but also with its MUFA
oleic acid-to-SFA palmitic acid ratio.
The increase in O2 consumption induced by physical
exercise is associated with an increase in reactive oxygen
species (ROS) production. These species induce oxidative
stress, a term generally used to describe the damage caused
by an imbalance between pro-oxidants and antioxidant de-
fense mechanisms (Leal Junior et al., 2011). Endothelial
oxidative stress is associated with impaired function and is
a key feature in the onset and evolution of CVD (Conti et
al., 2012). The increase in the MUFA oleic acid-to-SFA
palmitic acid ratio in postprandial TRL has been linearly
correlated with an increased down-regulation of the apoli-
poprotein B48 receptor (ApoB48R; a macrophage receptor
that binds to apolipoprotein B48 of dietary TRL), with a
consequent decrease in lipid accumulation (Varela et al.,
2013). This receptor may provide essential lipids, lipid-
soluble vitamins and other nutrients to reticuloendothelial
cells. When overwhelmed with elevated plasma trigly-
ceride levels, the apolipoprotein B48 receptor may contrib-
ute to foam cell formation, endothelial dysfunction and
atherothrombogenesis (Brown et al., 2000). These re-
sponses agree with the suggestion regarding the importance
of the MUFA oleic acid-to-SFA palmitic acid ratio indi-
cated above.
High concentrations of ROS result in damage to
DNA, proteins and lipids that can cause cell and tissue im-
pairment (Conti et al., 2012). Biomarkers of lipid oxida-
tion, such as malondialdehyde (MDA) measured as thio-
barbituric acid reactive substances (TBARS), may be
independent risk indicators for patients with stable coro-
nary artery disease (CAD), independently of traditional risk
factors and inflammatory markers (Walter et al., 2004). In
the present study done in athletes, the wild type GG geno-
type showed significantly higher MDA values than the
other IL-6 genotypes, a situation that was not improved by
supplementation with pequi oil. In addition, the Odds ratio
indicated an increased risk for higher MDA values among
females. Women have a lower risk of CVD than men be-
cause endogenous estrogens during the fertile period of life
delay the manifestation of atherosclerotic disease in wom-
en (Maas and Appelman, 2010). In the present study, only
athletes in their fertile period were investigated, with the
overall mean absolute level of TBARS being much lower
than that reported for patients with stable coronary artery
disease (1.49 ± 0.57 M or ng/dL) (Walter et al., 2004). In
addition, the absolute global CVD risk inspired by the
Framingham Heart Study is calculated based on a combina-
tion of several key risk factors that include the patients his-
tory of cardiovascular disease, diabetes, smoking, blood
pressure and blood lipid concentrations (Bitton and Gazia-
no, 2010). Pequi oil reportedly modulates postprandial
lipemia and reduces exercise-induced inflammation and
blood pressure in runners (Miranda-Vilela et al., 2009a).
Exercise induces transitory alterations in the se-
rum/plasma cytokine profile that involve mainly an in-
crease in serum levels of interleukin-6 (IL-6) (Oleto et al.,
2011). Although we did not quantify circulating IL-6 lev-
els, the significant reductions in CK and AST seen in indi-
viduals heterozygous for IL-6 and the non-significant re-
duction in these parameters observed for the other
genotypes in the before-after comparison of pequi-oil sug-
gested a better response to this antioxidant supplementation
against exercise-induced damage in the GC genotype. The
results of the platelet count corroborate our suggestion.
In conclusion, the IL-6 genotypes showed significant
differences in lipid peroxidation, with the CC mutant show-
ing lower values. There were also significant differences
among the genotypes with respect to the response to antiox-
idant supplementation with pequi oil, mainly in relation to
exercise-induced damage and CRP levels. The best re-
sponse against muscle damage was seen in the heterozy-
gous genotype, although the CC genotype showed an in-
crease in CRP levels after supplementation; the lack of a
positive correlation between triglycerides and hs-CRP for
this mutant genotype after supplementation indicated a pro-
tective effect of pequi oil. Because pequi oil has been asso-
ciated with an atherogenic effect, worsening the lipid pro-
file and at the same time modulating posprandial lipemia
and reducing exercise-induced inflammation and blood
pressure of human runners, these findings deserve further
investigations, in which evaluations of the IL-6 levels
should also be performed.
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